Wave Life Sciences insider sale notice — 25,000 shares planned

Rhea-AI Filing Summary

Wave Life Sciences Ltd. (WVE) Form 144 notice: An intended sale of 25,000 common shares is being reported with Morgan Stanley Smith Barney listed as the broker and an approximate aggregate market value of $244,000. The filing shows 159,140,460 shares outstanding and an approximate sale date of 08/22/2025. The shares were acquired on 03/05/2025 through previously exercised stock options and payment was made in cash on the same date. The filer also disclosed a prior sale within the past three months: 30,000 common shares sold on 06/13/2025 under a 10b5-1 plan for gross proceeds of $208,602. The notice includes the standard signature attestations that the seller is not aware of undisclosed material adverse information and references Rule 10b5-1 where applicable.

Insights

Securities Analyst

TL;DR: Routine insider transaction: exercised options sold via broker; size appears modest relative to outstanding shares.

The Form 144 documents a proposed sale of 25,000 common shares acquired through exercised stock options and paid in cash on the acquisition date. The use of a broker and an indicated sale date are consistent with a compliance-driven disposition rather than an operational disclosure. A 10b5-1 plan sale of 30,000 shares three months earlier is disclosed, indicating prior prearranged selling activity. There are no earnings figures, debt changes, or operational events disclosed in this filing to alter a company valuation. Impact on investors is limited unless aggregate insider selling is materially larger than disclosed here.

Corporate Governance Expert

TL;DR: Proper procedural filing showing exercised-option sale and prior 10b5-1 activity; no governance red flags presented.

The filing shows the seller represented compliance with disclosure rules and, if relying on a trading plan, referenced Rule 10b5-1 procedures. The transaction was funded in cash at exercise and is being routed through a broker for public sale. No resignations, related-party transactions, or undisclosed arrangements are stated. From a governance standpoint, the document is a standard notice of proposed sale with required attestations and does not present material governance concerns by itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	244000.00	159140460	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/05/2025	Previously Exercised Stock Options	ISSUER			25000	03/05/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GREGORY VERDINE 7 Straits View #12-00 Singapore U0 018936	Common	06/13/2025	30000	208602.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the WVE Form 144 propose to sell?

The notice proposes sale of 25,000 common shares with an aggregate market value of $244,000.

When is the approximate sale date reported on the WVE Form 144?

The filing lists an approximate sale date of 08/22/2025.

How were the 25,000 shares acquired according to the filing?

The shares were acquired on 03/05/2025 through previously exercised stock options and paid for in cash on that date.

Were there any recent sales by the same person disclosed in the Form 144?

Yes. The filing discloses a prior 10b5-1 sale of 30,000 common shares on 06/13/2025 for gross proceeds of $208,602.

What broker is listed for the proposed sale in the Form 144?

The broker named in the filing is Morgan Stanley Smith Barney LLC.